Premium
Nektar Therapeutics (NKTR)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| FMR LLC | Institution | 4 303 156 | 12,74% | US$ 255,22M | 2026-03-31 |
| BVF Partners L.P. | Institution | 2 559 595 | 7,58% | US$ 151,81M | 2026-03-31 |
| Two Seas Capital LP | Institution | 1 959 178 | 5,80% | US$ 116,20M | 2026-03-31 |
| Two Seas Global (Master) Fund Lp | Institution | 1 959 178 | 5,80% | US$ 116,20M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 365 482 | 4,04% | US$ 80,99M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 197 055 | 3,54% | US$ 71,00M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 997 300 | 2,95% | US$ 59,15M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 930 741 | 2,75% | US$ 55,20M | 2026-03-31 |
| Prosight Management, LP | Institution | 735 000 | 2,18% | US$ 43,59M | 2026-03-31 |
| BlackRock, Inc. | Institution | 692 650 | 2,05% | US$ 41,08M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 650 710 | 1,93% | US$ 38,59M | 2026-03-31 |
| Morgan Stanley | Institution | 637 935 | 1,89% | US$ 37,84M | 2026-03-31 |
| Armistice Capital LLC | Institution | 578 000 | 1,71% | US$ 34,28M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 513 531 | 1,52% | US$ 30,46M | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 509 546 | 1,51% | US$ 30,22M | 2026-03-31 |
| Invesco Ltd. | Institution | 425 341 | 1,26% | US$ 25,23M | 2026-03-31 |
| Woodline Partners LP | Institution | 415 335 | 1,23% | US$ 24,63M | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 405 080 | 1,20% | US$ 24,03M | 2026-03-31 |
| Millennium Management LLC | Institution | 404 277 | 1,20% | US$ 23,98M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 390 675 | 1,16% | US$ 23,17M | 2026-03-31 |
| UBS Asset Management AG | Institution | 354 197 | 1,05% | US$ 21,01M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 346 795 | 1,03% | US$ 20,57M | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 333 576 | 0,99% | US$ 19,78M | 2025-09-30 |
| Great Point Partners, LLC | Institution | 316 453 | 0,94% | US$ 18,77M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 285 000 | 0,84% | US$ 16,90M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 283 617 | 0,84% | US$ 16,82M | 2026-03-31 |
| 22NW, LP | Institution | 281 115 | 0,83% | US$ 16,67M | 2026-03-31 |
| PRIMECAP Management Company | Institution | 279 150 | 0,83% | US$ 16,56M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 275 000 | 0,81% | US$ 16,31M | 2026-03-31 |
| Gilder Gagnon Howe & Co. LLC | Institution | 271 758 | 0,80% | US$ 16,12M | 2026-03-31 |
| Nearwater Capital Markets, Limited | Institution | 261 500 | 0,77% | US$ 15,51M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 244 727 | 0,72% | US$ 14,51M | 2026-03-31 |
| JPMorgan Chase & Co. | Institution | 240 101 | 0,71% | US$ 14,24M | 2026-03-31 |
| Braidwell LP | Institution | 222 701 | 0,66% | US$ 13,21M | 2026-03-31 |
| Patient Square Capital, LP | Institution | 210 000 | 0,62% | US$ 12,46M | 2026-03-31 |
| Bronte Capital Management Pty Ltd | Institution | 198 256 | 0,59% | US$ 11,76M | 2026-03-31 |
| Quinn Opportunity Partners LLC | Institution | 179 247 | 0,53% | US$ 10,63M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 169 308 | 0,50% | US$ 10,04M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 168 007 | 0,50% | US$ 9,96M | 2026-03-31 |
| Dafna Capital Management, LLC | Institution | 165 178 | 0,49% | US$ 9,80M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
